Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Psychotherapy and Psychosomatics|March 13, 2001
Intact physiological response to arousal with impaired emotional recognition in alexithymiaL A Stone, K A Nielson
Diabetes Research (Edinburgh, Scotland)|December 1, 1990
Vitamin D receptors in intestine, kidney and thymus of streptozotocin diabetic ratsL A Stone, V M Weaver, M E Bruns, et al.
Journal of Neuroimmunology|May 1, 1996
Expression pattern of activation and adhesion molecules on peripheral blood CD4+ T-lymphocytes in relapsing-remitting multiple sclerosis patients: a serial analysisA Stüber, R Martin, L A Stone, et al.
Annals of Nutrition & Metabolism|January 1, 1991
Vitamin D receptors and compensatory tissue growth in spontaneously diabetic BB ratsL A Stone, V M Weaver, M E Bruns, et al.
Neurology|April 1, 1997
Clinical safety of serial monthly administrations of gadopentetate dimeglumine in patients with multiple sclerosis: implications for natural history and early-phase treatment trialsR M Tresley, L A Stone, N Fields, et al.
AJNR. American Journal of Neuroradiology|March 16, 2013
Sensorimotor cortex gamma-aminobutyric acid concentration correlates with impaired performance in patients with MSP K Bhattacharyya, M D Phillips, L A Stone, et al.
Neurology|April 2, 1999
A safety and pharmacokinetic study of intravenous natalizumab in patients with MSW A Sheremata, T L Vollmer, L A Stone, et al.
Neurology|May 1, 1997
Interferon beta results in immediate reduction of contrast-enhanced MRI lesions in multiple sclerosis patients followed by weekly MRIP A Calabresi, L A Stone, C N Bash, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 1, 1996
MRI studies of multiple sclerosis: implications for the natural history of the disease and for monitoring effectiveness of experimental therapiesH F McFarland, L A Stone, P A Calabresi, et al.
Annals of Neurology|January 1, 1994
Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing-remitting multiple sclerosis: implications for treatment trialsJ A Frank, L A Stone, M E Smith, et al.
Pageof 3